How Long to Wait When Switching From Mounjaro to Wegovy?
Understanding the Mounjaro to Wegovy Transition Timeline
When switching from Mounjaro to Wegovy, the waiting period between your last Mounjaro injection and your first Wegovy dose depends on several clinical factors. Most prescribers recommend a transition period of 3-7 days, allowing your previous medication to clear while minimising any gap in appetite control. This timeline for switching from Mounjaro to Wegovy ensures optimal therapeutic continuity whilst reducing the risk of overlapping side effects.
The key difference lies in their mechanisms—Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist, whilst Wegovy (semaglutide) targets GLP-1 receptors specifically. Your prescriber will determine the exact timing based on your current Mounjaro dose, how long you've been taking it, and your individual response. At EverydayMeds, our clinical team works with you to create a personalised switching schedule that maintains your weight management progress.
Cost Comparison: Switch and Save With Wegovy Pricing
Switching from Mounjaro to Wegovy often delivers substantial monthly savings, making it an attractive option for long-term weight management. Our Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with code FIRST40 for new customers), progressing to £209.99 for the 2.4mg maintenance dose. Compare this to typical Mounjaro costs, and many patients discover savings of £60-80 monthly once established on their maintenance dose.
Our bundle options provide even greater value and convenience when switching from Mounjaro to Wegovy. The Intro Trio bundle (0.25mg, 0.5mg, and 1mg) costs £299.99, covering your first 12 weeks of treatment with Reliable Supply continuity. Returning customers benefit from code DOSE25 at checkout, whilst our Ultimate Stability Trio (three 2.4mg pens) ensures three months of maintenance supply for £649.99—perfect for patients who've successfully transitioned and want to lock in their savings.
Clinical Evidence Supporting Your Switching Decision
The STEP clinical programme demonstrates Wegovy's robust efficacy profile, with patients achieving an average of clinically studied weight loss at 68 weeks when used alongside diet and exercise (Wilding et al., NEJM, 2021). These results may give you confidence when switching from Mounjaro to Wegovy, knowing you're transitioning to a well-evidenced treatment option. The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events, adding another dimension to the switch consideration.
Individual responses vary between GLP-1 medications, and some patients find Wegovy's single-receptor approach better suits their tolerance profile. The clinical evidence suggests that patients switching from Mounjaro to Wegovy typically maintain their weight loss trajectory, particularly when the transition is managed appropriately by healthcare professionals.
How Wegovy Works After Your Mounjaro Experience
Having experienced Mounjaro's dual-action approach, you'll find Wegovy's GLP-1 receptor agonist mechanism familiar yet distinct. Wegovy mimics your natural GLP-1 hormone, reducing appetite by acting on brain appetite centres and promoting satiety after smaller meals. Unlike Mounjaro's additional GIP receptor activity, Wegovy focuses specifically on GLP-1 pathways, which some patients find provides more predictable effects. The once-weekly injection schedule remains the same, maintaining the convenience you're accustomed to. This targeted approach often results in different side effect patterns, which may be why you're considering switching from Mounjaro to Wegovy in the first place.
Your EverydayMeds Switching Process
Switching from Mounjaro to Wegovy through EverydayMeds involves a streamlined 3-minute online clinical assessment where you'll detail your current treatment experience and switching goals. Our prescribers review your case within 3 working days (or 24 hours with express service), creating a personalised transition plan that considers your Mounjaro dose history and any side effects experienced. Once approved, your Wegovy arrives via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transit. Our pharmacy team remains available for switching support, ensuring you feel confident throughout the transition. As a GPhC-registered pharmacy (#9012878), we maintain full clinical records of both your Mounjaro history and new Wegovy prescription for continuity of care.
Storage Advantages When Switching to Wegovy
One compelling reason for switching from Mounjaro to Wegovy is the superior storage flexibility that Wegovy offers. Whilst both medications require refrigeration before first use, Wegovy can be stored at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This makes Wegovy ideal for frequent travelers or those with unpredictable schedules. The FlexTouch pen design is user-friendly, and you'll follow the same dose escalation principle—starting at 0.25mg even if you were on a higher Mounjaro dose. Your prescriber will ensure the transition maintains your therapeutic progress whilst optimising the practical benefits.
Dose Conversion Strategy for Mounjaro to Wegovy Switching
The dose conversion when switching from Mounjaro to Wegovy isn't a direct milligram-to-milligram translation due to their different mechanisms of action. Most prescribers restart Wegovy at the standard 0.25mg dose regardless of your final Mounjaro dose, then escalate according to the licensed schedule. This approach minimises side effects whilst allowing your system to adapt to the single-receptor mechanism. Your previous Mounjaro experience provides valuable insights into your GLP-1 tolerance, potentially allowing for faster escalation if appropriate.
Some patients worry about losing progress when switching from Mounjaro to Wegovy, but clinical experience suggests that appetite control typically continues throughout the transition period. The key is maintaining your reduced-calorie diet and increased physical activity during the switch. Our clinical team monitors your transition closely, adjusting the escalation timeline based on your response and ensuring your weight management goals remain on track.
Complete Your Switch With EverydayMeds Today
Ready to make the switch from Mounjaro to Wegovy? Our comprehensive service ensures a smooth transition with potential monthly savings and improved storage convenience. New customers use code FIRST40 at checkout, whilst returning customers benefit from code DOSE25—both applied automatically to reach our competitive pricing. Visit https://everydaymeds.co.uk/collections/weight-loss to start your clinical assessment and discuss your switching timeline with our prescribers. Our express review service is available if you need urgent switching support. As a prescription-only medicine, Wegovy requires proper medical oversight, and our GPhC-registered team (#9012878) ensures you receive expert guidance throughout your transition journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
